Inventor · disambiguated record

Niranjan Rao

Also filed as: RAO NIRANJAN

5 granted patents·21 pending applications·61 citations·filing 2005–2024

74Inventor score

Technology areasA61P A61K

Files withFOREST LAB HOLDINGS LTD10 ASANA BIOSCIENCES LLC4 FOREST LABORATORIES4 FOREST LABORATORIES HOLDINGS LTD3 LIBERTAS BIO INC2

Top patents by PatentIndex Score

26 records

0192US8039009B2Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2005·Granted Oct 18, 2011·61 cites·23 claims
0269US12036224B2Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2023·Granted Jul 16, 2024·0 cites·26 claims
0369US2024307398A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2024·Application pending·0 cites
0467US2020268685A1Modified release formulations of memantine oral dosage formsFOREST LABORATORIES HOLDINGS LTD·Filed 2020·Application pending·0 cites
0565US2013302430A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
0663US10660868B2Modified release formulations of memantine oral dosage formsFOREST LABORATORIES HOLDINGS LTD·Filed 2016·Granted May 26, 2020·0 cites·8 claims
0763US2010028427A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2009·Application pending·0 cites
0861US2014213659A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
0960US2012201889A1Modified and immediate release formulations of memantineDEDHIYA MAHENDRA G·Filed 2012·Application pending·0 cites
1060US2016346227A1Modified and immediate release formulations of memantineFOREST LABORATORIES HOLDINGS LTD·Filed 2016·Application pending·0 cites
1160US2013310460A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
1260US2015258042A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
1359US2014348932A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
1458US2013012593A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
1557US2007065512A1Modified and immediate release formulations of memantineFOREST LABORATORIES·Filed 2006·Application pending·0 cites
1657US2013011474A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
1754US2015258031A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
1854US2012004318A1Modified release formulations of memantine oral dosage formsRASTOGI SUNEEL K·Filed 2011·Application pending·0 cites
1954US2006198884A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
2053US8834924B2Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneYANG YAN·Filed 2011·Granted Sep 16, 2014·0 cites·19 claims
2153US2015148427A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
2253US2006002999A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
2351US2019008868A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Application pending·0 cites
2449US2023027072A1Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2ASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
2546US10695296B2Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Granted Jun 30, 2020·0 cites·28 claims
2645US2022000853A1Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2019·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Niranjan Rao files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →